Dexcom Inc
DXCM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001093557
In the last 90 days, Dexcom Inc insiders filed 0 open-market purchases and 12 sales; 976 institutions reported holding it in 13F filings for Q2 2026, worth $26.0B in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Dexcom Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 933 | 13 | 939 | +19 |
| Shares | 364.3M | 180.2K | 366.1M | +1.97M (+0.5%) |
| Value | $24.8B | $12.3M | $31.9B | +$7.11B (+28.7%) |
13 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (124)
Institutions that held Dexcom Inc at the end of Q2 2025 but not at the end of Q1 2025.
Showing the largest 100 of 124 by value.
Sold out (105)
Institutions that held Dexcom Inc at the end of Q1 2025 and filed for Q2 2025 without it.
Showing the largest 100 of 105 by value.
Not filed for Q2 2025 yet (13)
Institutions that held Dexcom Inc at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Rakuten Investment Management, Inc. | 49,983 | $3.39M |
| Credit Agricole S A | 48,134 | $3.29M |
| Mizuho Securities USA LLC | 31,283 | $2.14M |
| Orion Portfolio Solutions, LLC | 29,411 | $2.01M |
| Glenmede Trust Co NA | 7,211 | $492.4K |
| CAPROCK Group, Inc. | 4,534 | $309.6K |
| Taurus Asset Management, LLC | 3,800 | $259.5K |
| Pilgrim Partners Asia Pte Ltd | 3,000 | $204.9K |
| Lindbrook Capital, LLC | 1,882 | $128.5K |
| Sandy Spring Bank | 800 | $54.6K |
| Financial Network Wealth Management LLC | 160 | $10.0K |
| Nova Wealth Management, Inc. | 36 | $2.46K |
| Spectrum Wealth Counsel, LLC | 5 | $342 |